Page last updated: 2024-08-21

pyrazines and Thyroid Carcinoma, Anaplastic

pyrazines has been researched along with Thyroid Carcinoma, Anaplastic in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, KY; Fagin, JA; Ghossein, R; Knauf, JA; Luckett, KA; Socci, ND; Voza, F1
Ahn, BC; Baek, SH; Gangadaran, P; Hong, CM; Jeong, SY; Kalimuthu, SK; Lee, HW; Lee, J; Lee, SW; Li, XJ; Min, OJ; Rajendran, RL; Zhu, L1
Altmann, A; Askoxylakis, V; Eisenhut, M; Haberkorn, U; Jesenofsky, R; Markert, A; Schöning, T1

Other Studies

3 other study(ies) available for pyrazines and Thyroid Carcinoma, Anaplastic

ArticleYear
Hgf/Met activation mediates resistance to BRAF inhibition in murine anaplastic thyroid cancers.
    The Journal of clinical investigation, 2018, 08-31, Volume: 128, Issue:9

    Topics: Amino Acid Substitution; Animals; Antineoplastic Agents; Cell Line, Tumor; Coumarins; Crizotinib; Disease Models, Animal; Drug Resistance, Neoplasm; Genes, p53; Humans; Indoles; MAP Kinase Signaling System; Mice; Mice, Transgenic; Mutation, Missense; Protein Kinase Inhibitors; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-met; Pyrazines; Sulfonamides; Thyroid Carcinoma, Anaplastic; Thyroid Neoplasms; Triazoles

2018
New Optical Imaging Reporter-labeled Anaplastic Thyroid Cancer-Derived Extracellular Vesicles as a Platform for In Vivo Tumor Targeting in a Mouse Model.
    Scientific reports, 2018, 09-10, Volume: 8, Issue:1

    Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Disease Models, Animal; Drug Carriers; Extracellular Vesicles; Female; Genes, Reporter; Humans; Imidazoles; Luciferases, Renilla; Luminescent Agents; Mice; Mice, Nude; Optical Imaging; Pyrazines; Thyroid Carcinoma, Anaplastic; Thyroid Neoplasms; Xenograft Model Antitumor Assays

2018
Antitumor effects of proteasome inhibition in anaplastic thyroid carcinoma.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2012, Volume: 53, Issue:11

    Topics: Animals; Antineoplastic Agents; Apoptosis; Boronic Acids; Bortezomib; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Female; Humans; Mice; Mice, Inbred BALB C; Organ Specificity; Proteasome Endopeptidase Complex; Proteasome Inhibitors; Pyrazines; Thyroid Carcinoma, Anaplastic; Thyroid Neoplasms; Up-Regulation; Xenograft Model Antitumor Assays

2012